Literature DB >> 16476148

Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia.

Brian Dean1, Laura Gray, Elizabeth Scarr.   

Abstract

OBJECTIVE: To determine if levels of the glial-derived proteins S100beta and glial acidic fibrillary protein (GFAP) and the pro- and antiapoptotic proteins p53 and Bcl-2 were altered in the cortex of subjects with schizophrenia or bipolar 1 disorder.
METHOD: Levels of S100beta, GFAP, p53 and Bcl-2 were measured in cortex (Brodmann's Areas (BAs) 9, 10, 46 and 40) of control subjects and subjects with schizophrenia, bipolar 1 disorder and in the cortex of rats treated with haloperidol or lithium using protein-specific antibodies and western blot analysis.
RESULTS: Levels of S100beta were decreased in BA 9 and increased in BA 40 from subjects with bipolar 1 disorder. Levels of this protein were not altered in other CNS regions, in schizophrenia or in the cortex of rats treated with haloperidol or lithium. No changes in levels of the other three proteins were detected across diagnoses.
CONCLUSIONS: Regionally selective changes in cortical S100beta may be associated with the pathology of bipolar 1 disorder and may reflect derangements in neuronal death or survival.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476148     DOI: 10.1080/j.1440-1614.2006.01777.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  19 in total

Review 1.  (Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia.

Authors:  Allyson P Mallya; Ariel Y Deutch
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 2.  Astrocyte regulation of synaptic signaling in psychiatric disorders.

Authors:  Anna Kruyer; Peter W Kalivas; Michael D Scofield
Journal:  Neuropsychopharmacology       Date:  2022-05-16       Impact factor: 7.853

Review 3.  Astrocytes in Neuropsychiatric Disorders: A Review of Postmortem Evidence.

Authors:  Xiaolu Zhang; Rawan S Alnafisah; Abdul-Rizaq A Hamoud; Rammohan Shukla; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Adv Neurobiol       Date:  2021

4.  Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.

Authors:  Amy E Steffek; Robert E McCullumsmith; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2008-06-17       Impact factor: 4.939

5.  Mood disorders are glial disorders: evidence from in vivo studies.

Authors:  Matthias L Schroeter; Hashim Abdul-Khaliq; Julia Sacher; Johann Steiner; Ingolf E Blasig; Karsten Mueller
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-05-27

6.  Selection of reference gene expression in a schizophrenia brain cohort.

Authors:  Cynthia Shannon Weickert; Donna Sheedy; Debora A Rothmond; Irina Dedova; Samantha Fung; Therese Garrick; Jenny Wong; Antony J Harding; Sinthuja Sivagnanansundaram; Clare Hunt; Carlotta Duncan; Nina Sundqvist; Shan-Yuan Tsai; Jasna Anand; Daren Draganic; Clive Harper
Journal:  Aust N Z J Psychiatry       Date:  2010-01       Impact factor: 5.744

7.  Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex.

Authors:  Yunyoung C Chang; Stanley I Rapoport; Jagadeesh S Rao
Journal:  Neurochem Res       Date:  2008-08-22       Impact factor: 3.996

Review 8.  Bipolar disorder and mechanisms of action of mood stabilizers.

Authors:  Stanley I Rapoport; Mireille Basselin; Hyung-Wook Kim; Jagadeesh S Rao
Journal:  Brain Res Rev       Date:  2009-06-23

9.  Dissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.

Authors:  Brian Dean
Journal:  Schizophr Res Treatment       Date:  2011-06-18

Review 10.  Role of Astrocytes in Major Neuropsychiatric Disorders.

Authors:  Xiaolu Zhang; Rawan S Alnafisah; Abdul-Rizaq A Hamoud; Rammohan Shukla; Zhexing Wen; Robert E McCullumsmith; Sinead M O'Donovan
Journal:  Neurochem Res       Date:  2021-01-07       Impact factor: 4.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.